Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN50867461Phase 2Completed
Phase 2 trial of tranexamic acid in intracerebral hemorrhage (ICH) (2 arms), sponsored by University of Nottingham. Primary endpoints: Acceptability and Tolerability. Started Dec 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN50867461.